Local Site Tolerability of Multiple Dose Treatment With Deltoid Intramuscular Injection of RISPERDAL CONSTA in Subjects With Chronic Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 20 Mar 2010
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Registrational
- Sponsors Janssen Research & Development
- 20 Mar 2010 Actual patient number (53) added as reported by ClinicalTrials.gov.
- 30 Jan 2009 New trial record